This interpretation might be consistent with a report by Endre and colleagues, who described the improvement of new urinary AKI biomarkers, including NGAL, cystatin C, KIM-1 and interleukin-18 by stratification with baseline renal function [14]. The gene discussed is LCN2; the disease is acute kidney injury.